Filter your results
- 3
- 1
- 4
- 4
- 1
- 1
- 2
- 4
- 3
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Ocular injuries caused by less-lethal weapons in FranceThe Lancet, 2019, 394 (10209), pp.1616-1617. ⟨10.1016/S0140-6736(19)31807-0⟩
Journal articles
hal-02545485v1
|
||
|
Infliximab versus adalimumab in the treatment of refractory inflammatory uveitis: Multicenter study from the french uveitis networkArthritis & rheumatology, 2016, 66 (6), pp.1522-1530. ⟨10.1002/art.39667⟩
Journal articles
hal-01301142v1
|
||
|
Intravenous high-dose methotrexate based systemic therapy in the treatment of isolated primary vitreoretinal lymphoma: an LOC network studyAmerican Journal of Hematology, 2021, 96 (7), pp.823-833. ⟨10.1002/ajh.26199⟩
Journal articles
hal-03228816v1
|
||
|
ISOLD: A New Highly Sensitive Interleukin Score for Intraocular Lymphoma DiagnosisOphthalmology: Journal of The American Academy of Ophthalmology, 2016, 123 (7), pp.1626-1628. ⟨10.1016/j.ophtha.2016.01.037⟩
Journal articles
hal-01290416v1
|